HON — Honeywell International Inc.

As of 2026-08-27, sentiment is cautious but not panicked: the stock is down toward the lower half of its 52-week range, RSI was 40.41, and price is below its 20- and 50-day moving averages. The Q2 2026 adjusted EPS beat and raised organic growth guidance provide a fundamental floor, but margin compression, post-spin data noise, and soft technical momentum keep the market from turning bullish.

Pre-spinoff, from 2023-Q3 through 2025-Q3, revenue grew roughly 5-8% YoY and operating margins were generally in the 17-21% range, with most quarters near 20%. The 2025-Q4 print - $6.86B revenue and a -$115M net loss - is a structural break caused by the aerospace separation and related charges, not an ordinary blip. In 2026, reported revenue of $9.14B and $9.72B in Q1/Q2 is down ~6-7% versus the old combined entity, and operating margin compressed to 9.7% in Q1 and 17.9% in Q2. Underlying order growth of +16% YoY and a $19B+ backlog suggest demand is inflecting higher, but the reported trend cannot be trusted until the new segment composition is fully annualized.

As of 2026-08-27, the reported P/E of 8.55 is not meaningful because TTM EPS of $25.89 includes a massive one-off gain in Q2 2026 (EPS $17.81). On next-FY EPS estimate of $8.325, the stock trades at roughly 26.5x forward earnings, well above a reasonable 20-24x range for a 3-4% organic grower with ~18% operating margins. The trailing P/S of 1.93 also mixes in old aerospace revenue; on estimated post-spin revenue near $20.2B, the forward P/S is closer to 3.5x. The 3.35% dividend yield looks optically high but implies an ~89% payout against forward EPS, so the dividend likely gets reset. The 'cheap vs. its own history' label is largely an artifact of one-off earnings inflation.

The market is not pricing in a cheap turnaround; at $220.39 it is paying ~26.5x the $8.325 forward EPS estimate. That means expectations already include margin recovery and backlog conversion. If Q3 2026 shows operating margins back above 19-20% and organic growth at or above the guided 3-4%, EPS estimates can migrate higher and the stock works. If margins stay near 17-18% or backlog conversion slows, the multiple is vulnerable to a de-rate toward the low $200s or below.

As of 2026-08-27, RSI was 40.41 - weak but not oversold. Price was 4.89% below the 20-day SMA, 4.48% below the 50-day SMA, and essentially flat at -0.42% versus the 200-day SMA. This is a range-bound, no-momentum profile between the 52-week low of $195.87 and high of $260.28. Support is around $195-$200, and resistance sits near the 50-day moving average; a reclaim of the 50-day would improve the entry setup, while a break below the 200-day would increase downside risk.

• Rising long-term Treasury yields and rotation out of industrial cyclicals are pressuring multi-industry multiples.
• Persistent cost-of-sales inflation (+7.2% YoY) and R&D cost inflation (+14.2% YoY) are squeezing near-term operating margins.
• Structural tailwinds from AI data-center power demand, grid automation, and energy-transition/LNG capex benefit the new Honeywell portfolio.
• Post-spin portfolio simplification could lead to multiple re-rating, but execution and divestiture risk remain.
• Geopolitical risk-off flows toward energy and healthcare are pulling capital away from broad industrials.

• Q3 2026 earnings in late October 2026 - first clean quarter under the reorganized post-aerospace framework; focus on operating margin and free-cash-flow conversion.
• October 2026 executive transition in Process Technology and Building Automation could drive structural margin improvements if new leadership executes.
• Order backlog conversion: +16% order growth against a $19B+ backlog should start showing up in reported revenue.
• Continued portfolio cleanup and integration of the Johnson Matthey Catalyst Technologies acquisition into energy-transition and LNG capabilities.

• Post-spin operating margin compression persists - Q2 2026 operating margin was ~17.9% versus ~20% a year earlier, and Q1 2026 was only 9.7%.
• Forward multiple of ~26.5x on normalized EPS leaves little room for estimate misses or macro disappointment.
• Dividend sustainability is questionable if payout is ~89% of forward EPS, creating headline risk of a dividend reset.
• Leverage is elevated with debt-to-equity of 1.35; higher-for-longer rates increase interest costs and multiple pressure.
• Spin-off-related financial distortion makes underlying momentum hard to verify, increasing the risk of misreading the trend.

As of 2026-08-27, I would not chase HON at $220.39. The post-spin business has genuine order momentum, a large backlog, and a reasonable balance sheet, but the stock already trades at a premium forward multiple while margins are still compressed. The risk/reward is balanced to slightly unfavorable; I want to see Q3 2026 evidence of margin recovery and better technical momentum before getting more constructive.

I applied a 24.0x normalized forward P/E to the next-FY EPS estimate of $8.325, yielding $199.80. The 24x multiple is a modest discount to the stock's current implied 26.5x forward multiple, reflecting post-spin margin compression, elevated leverage, and execution risk, while still crediting the strong backlog, order growth, and free-cash-flow generation.